Page last updated: 2024-11-04

sb 202190 and Carcinoma, Anaplastic

sb 202190 has been researched along with Carcinoma, Anaplastic in 2 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Research Excerpts

ExcerptRelevanceReference
"Human colon cancer cells (Caco-2) were stimulated with increasing concentrations of sodium chloride (NaCl) or LPS."1.31Epithelial cyclooxygenase-2 expression: a model for pathogenesis of colon cancer. ( Arbabi, S; Garcia, I; Jelacic, S; Maier, RV; Rosengart, MR, 2001)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chao, JI1
Kuo, PC1
Hsu, TS1
Arbabi, S1
Rosengart, MR1
Garcia, I1
Jelacic, S1
Maier, RV1

Other Studies

2 other studies available for sb 202190 and Carcinoma, Anaplastic

ArticleYear
Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells.
    The Journal of biological chemistry, 2004, May-07, Volume: 279, Issue:19

    Topics: Antineoplastic Agents; Apoptosis; Arsenites; Benzazepines; Blotting, Western; Carcinoma; CDC2 Protei

2004
Epithelial cyclooxygenase-2 expression: a model for pathogenesis of colon cancer.
    The Journal of surgical research, 2001, May-01, Volume: 97, Issue:1

    Topics: Carcinoma; Colonic Neoplasms; Cyclooxygenase 2; Dose-Response Relationship, Drug; Enzyme Inhibitors;

2001